| |
|
News |
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | Archived |
December 9, 2008 |
Gemin X Presents New Data on Obatoclax at the American Society of Hematology Meeting
|
December 2, 2008 |
Gemin X Announces Data Presentations for its Novel, Targeted Cancer Therapy Obatoclax at the 50th Annual American Society of Hematology Meeting and Exposition |
October 31, 2008 |
Gemin X Announces Data Presentation for its Novel, Targeted Cancer Therapy Obatoclax at the 26th Chemotherapy Foundation Symposium |
October 28, 2008 |
Gemin X Pan Bcl-2 Inhibitor Obatoclax Demonstrates Biological and Clinical Activity in
Heavily Pre-treated Patients with Advanced Chronic Lymphocytic Leukemia |
October 24, 2008 |
Key Data Presented for Gemin X Programs at the 20th Annual ENA Symposium |
October 22, 2008 |
Gemin X to Present at The 7th Annual BIO Investor Forum |
October 16, 2008 |
Gemin X Announces Data Presentations for its Novel, Targeted Cancer Therapies Obatoclax and GMX1777 at the 20th Annual EORTC-NCI-AACR Symposium |
September 23, 2008 |
Gemin X Announces Key U.S. Patent Issued for Obatoclax |
July 8, 2008 |
Gemin X Pharmaceuticals Appoints Peter R. Dolan to Board of Directors |
| June 30, 2008 |
Gemin X Pharmaceuticals, Inc. Closes $38 Million Series C Financing to Advance Lead Cancer Drug, Obatoclax, Into Registration Trials |
June 10, 2008 |
Senior Pharmaceutical Executive, Glenn J. Gormley, M.D., Ph.D., to Lead Gemin X Pharmaceuticals as President and CEO |
| March 20, 2008 |
Gemin X Pharmaceuticals to Present Mechanism-of-Action of Novel Anti-Cancer Compound at the 15th International Molecular Medicine Tri-Conference |
| |
|
|
|
